Cutler Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Cutler Group’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-38	Closed	-$2K	–	6492
2021 Q2	$2K	Buy	38 +10	+36%	+$951	﹤0.01%	5120
2021 Q1	$2K	Buy	+28	New	+$3.1K	﹤0.01%	5053
2018 Q3	–	Sell	-20	Closed	-$1K	–	4812
2018 Q2	$1K	Hold	20	–	–	﹤0.01%	3996
2018 Q1	$2K	Sell	20 -9	-31%	-$1.76K	﹤0.01%	3875
2017 Q4	$2K	Buy	29 +15	+107%	+$3.12K	﹤0.01%	4250
2017 Q3	$2K	Buy	14 +9	+180%	+$1.66K	﹤0.01%	5205
2017 Q2	$2K	Sell	5 -85	-94%	-$13.5K	﹤0.01%	5650
2017 Q1	$13K	Sell	90 -100	-53%	-$29.4K	﹤0.01%	3806
2016 Q4	$37K	Sell	190 -30	-14%	-$11.2K	﹤0.01%	2856
2016 Q3	$31K	Buy	+220	New	+$77.1K	﹤0.01%	2980

Other funds holding CSCI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cutler Group's CSCI Position: Q4 2022 in Review

Cutler Group sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2022, closing a stake of 57 shares.

Cutler Group first reported a position in CSCI in Q3 2016 and held it in 24 quarters. The position peaked at $69K in Q4 2016. 13 funds tracked by Wall St. Rank hold CSCI as of Q4 2022.

Cutler Group reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Cutler Group sold 57 COSCIENS Biopharma Inc. Common Stock shares in Q4 2022.
Cutler Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2016 and held it in 24 quarters.
Cutler Group's COSCIENS Biopharma Inc. Common Stock position peaked at $69K in Q4 2016.
13 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.